Abstract
Superior mesenteric artery (SMA) syndrome is a rare disease, characterized by the narrowing of the third portion of the duodenum between the aorta and SMA. The cause of the stenosis is a decrease in retroperitoneal fat between the aorta and SMA. In this report, we present two cases of SMA syndrome that occurred during chemotherapy for lung cancer. The first case was a 61-year-old male treated with nanoparticle albumin-bound-paclitaxel (nab-PTX) for lung adenocarcinoma. On day 23 of the first course of nab-PTX, he was admitted to our hospital due to vomiting and weight loss of 15.6 kg in 10 months. He was diagnosed with SMA syndrome through computed tomography, and drainage was performed using a nasogastric tube. Conservative treatment was successful, and the patient was able to continue therapy with nab-PTX. The second case was a 70-year-old male with epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer. He was admitted to our hospital due to vomiting and dizziness while receiving treatment with pembrolizumab, as well as weight loss of 14.6 kg in 6 months. He was diagnosed with SMA syndrome using computed tomography. Conservative treatment using a nasogastric tube led to improvement, and the patient was able to continue treatment with pembrolizumab after discharge. This is the first report of SMA syndrome in patients with lung cancer undergoing chemotherapy with nab-PTX or pembrolizumab. Late diagnosis and treatment render SMA syndrome a potentially fatal disease. Vomiting and weight loss during chemotherapy are known treatment-related side effects; in patients developing these adverse effects, the presence of SMA syndrome should be suspected and managed appropriately.
Similar content being viewed by others
Abbreviations
- BMI:
-
Body mass index
- CT:
-
Computed tomography
- EGFR:
-
Epidermal growth factor receptor
- nab-PTX:
-
Nanoparticle albumin-bound-paclitaxel
- SMA:
-
Superior mesenteric artery
References
Welsch T, Büchler MW, Kienle P (2007) Recalling superior mesenteric artery syndrome. Dig Surg 24:149–156
Matheus Cde O, Waisberg J, Zewer MH, Godoy AC (2005) Syndrome of duodenal compression by the superior mesenteric artery following restorative proctocolectomy: a case report and review of literature. Sao Paulo Med J 123:151–153
Young A, Kinnear N, Hennessey D et al (2018) Intermittent superior mesenteric artery syndrome in a patient with multiple sclerosis. Radiol Case Rep 13:1108–1111
Haidar A, Davies A, Hussain A et al (2020) Wilkie’s weight loss wonder, a case series. Spartan Med Res J 15:13485
Shi Y, Shi G, Li Z et al (2019) Superior mesenteric artery syndrome coexists with Nutcracker syndrome in a female: a case report. BMC Gastroenterol 19:15
Ushiki A, Koizumi T, Yamamoto H et al (2012) Superior mesenteric artery syndrome following initiation of cisplatin-containing chemotherapy: a case report. J Med Case Rep 6:14
Chowdhary M, Pansuria HP, Farooqi B et al (2015) Superior mesenteric artery syndrome: a unique complication following carboplatin-based chemotherapy. Int Med Case Rep J 8:55–58
Ahmed AR, Taylor I (1997) Superior mesenteric artery syndrome. Postgrad Med J 73:776–778
Iwaoka Y, Yamada M, Takehira Y et al (2001) Superior mesenteric artery syndrome in identical twin brothers. Intern Med 40(8):713–715
Merrett ND, Wilson RB, Cosman P et al (2009) Superior mesenteric artery syndrome: diagnosis and treatment strategies. J Gastrointest Surg 13:287–292
Ganss A, Rampado S, Savarino E et al (2019) Superior mesenteric artery syndrome: a prospective study in a single institution. J Gastrointest Surg 23:997–1005
Unal B, Aktaş A, Kemal G et al (2005) Superior mesenteric artery syndrome: CT and ultrasonography findings. Diagn Interv Radiol 11:90–95
Neri S, Signorelli SS, Mondati E et al (2005) Ultrasound imaging in diagnosis of superior mesenteric artery syndrome. J Intern Med 257:346–351
Chang J, Boules M, Rodriguez J et al (2017) Laparoscopic duodenojejunostomy for superior mesenteric artery syndrome: intermediate follow-up results and a review of the literature. Surg Endosc 31:1180–1185
Deshpande SH, Thomas J, Chiranjeev R, et al (2021) Superior mesenteric artery syndrome in a patient with celiacomesenteric trunk. BMJ Case Rep 14:e237132.
Salem A, Al Ozaibi L, Nassif SMM et al (2017) Superior mesenteric artery syndrome: A diagnosis to be kept in mind (case report and literature review). Int J Surg Case Rep 34:84–86
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors report no conflicts of interest in this work.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Miyadera, K., Nakamichi, S., Miyashita, R. et al. Two cases of superior mesenteric artery syndrome during chemotherapy in patients with lung cancer. Int Canc Conf J 11, 124–128 (2022). https://doi.org/10.1007/s13691-022-00534-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13691-022-00534-1